Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003171
Recruitment Status : Completed
First Posted : July 19, 2004
Last Update Posted : April 5, 2013
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Barbara Ann Karmanos Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 1999
  Study Completion Date : June 2003